Albireo Pharma (FRA:BDQM) Operating Cash Flow per Share : €-5.58 (TTM As of Sep. 2022)

View and export this data going back to 2007. Start your Free Trial

What is Albireo Pharma Operating Cash Flow per Share?

Albireo Pharma's operating cash flow per share for the three months ended in Sep. 2022 was €-1.52. Albireo Pharma's operating cash flow per share for the trailing twelve months (TTM) ended in Sep. 2022 was €-5.58.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -34.70% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -6.30% per year. During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 26.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Albireo Pharma's Operating Cash Flow per Share or its related term are showing as below:

FRA:BDQM' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -50.9 Med: 27.85 Max: 48.8
Current: -34.7

During the past 13 years, Albireo Pharma's highest 3-Year average Operating Cash Flow per Share Growth Rate was 48.80% per year. The lowest was -50.90% per year. And the median was 27.85% per year.

FRA:BDQM's 3-Year OCF Growth Rate is not ranked
in the Biotechnology industry.
Industry Median: 3.55 vs FRA:BDQM: -34.70

Albireo Pharma Operating Cash Flow per Share Historical Data

The historical data trend for Albireo Pharma's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Albireo Pharma Operating Cash Flow per Share Chart

Albireo Pharma Annual Data

Trend

Sep12

Sep13

Sep14

Sep15

Sep16

Dec17

Dec18

Dec19

Dec20

Dec21

Operating Cash Flow per Share

Get a 7-Day Free Trial

-2.98

-2.01

-3.83

-5.20

-4.95

Albireo Pharma Quarterly Data
	Dec17	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
Operating Cash Flow per Share	Get a 7-Day Free Trial															-1.19	-0.64	-1.66	-1.76	-1.52

Competitive Comparison of Albireo Pharma's Operating Cash Flow per Share

For the Biotechnology subindustry, Albireo Pharma's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Albireo Pharma's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Albireo Pharma's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Albireo Pharma's Price-to-Operating-Cash-Flow falls into.

Albireo Pharma Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Albireo Pharma's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2021 is calculated as

Operating Cash Flow per Share (A: Dec. 2021 )	=	Cash Flow from Operations (A: Dec. 2021 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2021 )
	=	-95.19	/	19.221
	=	-4.95

Albireo Pharma's Operating Cash Flow per Share for the quarter that ended in Dec. 2021 is calculated as

Operating Cash Flow per Share (Q: Sep. 2022 )	=	Cash Flow from Operations (Q: Sep. 2022 )	/	Shares Outstanding (Diluted Average) (Q: Sep. 2022 )
	=	-29.926	/	19.655
	=	-1.52

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Sep. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was €-5.58

Albireo Pharma Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Albireo Pharma's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Albireo Pharma (FRA:BDQM) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Albireo Pharma Inc (FRA:BDQM) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

53 State Street, 19th Floor, Boston, MA, USA, 02109

Website

https://www.albireopharma.com

Albireo Pharma Inc is a commercial-stage biopharmaceutical company. It focuses on the development and commercialization of novel bile acid modulators to treat orphan pediatric liver diseases and other liver and gastrointestinal diseases and disorders. The Company's product pipeline includes Bylvay, which is approved in the United States and Europe; elobixibat, which is approved in Japan for the treatment of chronic constipation; A3907, its Phase 1 lead candidate for the treatment of adult liver diseases; and A2342, it's a lead preclinical candidate for the treatment of adult viral and liver diseases.

Albireo Pharma (FRA:BDQM) Headlines

No Headlines